ADMA Biologics, Inc.

NASDAQ:ADMA

Biotechnology

Healthcare
$13.34 +0.42%

+$0.04 today

Market cap
$2.96B
Beta
0.73
P/E (TTM)
12.1
EPS (TTM)
$0.70
52W Low $7.21High $20.46

Volume 3.62M

Average 7.07M

Balance Sheet

Inspect the capital base behind the business.

Assets

$624.24M

FY 2025 · Annual

+27.7% YoY

Liabilities

$146.92M

FY 2025 · Annual

+5.2% YoY

Equity

$477.32M

FY 2025 · Annual

+36.8% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents51.09M86.52M51.35M103.15M87.63M
Short-term Investments00000
Net Receivables28.58M15.51M27.42M50M158.43M
Inventory124.72M163.28M172.91M170.24M206.47M
Other Current Assets05.1M5.33M8.03M13.99M
Total Current Assets208.73M270.4M257.01M331.41M466.51M
Property, Plant & Equipment (Net)58.2M68.75M63.47M63.34M71.71M
Goodwill3.53M3.53M3.53M3.53M3.53M
Intangible Assets1.73M1.01M499K460K632K
Long-term Investments00000
Tax Assets00084.28M73.26M
Other Non-current Assets4.07M4.77M4.67M5.66M8.6M
Total Non-current Assets67.52M78.06M72.17M157.27M157.73M
Total Assets276.25M348.46M329.18M488.68M624.24M
Account Payables12.43M13.23M15.66M20.22M22.52M
Short-term Debt00002.81M
Tax Payables0003.48M0
Deferred Revenue142.83K143K182K143K0
Other Current Liabilities16.05M1.8M2.37M1.85M6.82M
Total Current Liabilities30.38M39.27M49.81M55.54M69.54M
Long-term Debt94.87M142.83M130.59M72.34M69.33M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)1.98M1.83M1.69M1.55M1.41M
Other Non-current Liabilities397.35K1.85M2.11M1.67M0
Total Non-current Liabilities104.7M157.22M144.17M84.12M77.38M
Total Liabilities135.08M196.49M193.98M139.66M146.92M
Common Stock19.58K22K23K24K24K
Retained Earnings(412.11M)(478.02M)(506.26M)(308.58M)(161.65M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity141.17M151.97M135.21M349.02M477.32M
Total Debt102.92M154.44M141.42M82.12M79.89M
Net Debt51.83M67.92M90.07M(21.03M)(7.75M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$136.0M
Receivables$138.2M
Inventory$239.3M
Other Current$14.6M
Total Current Assets$528.2M
PP&E (Net)$72.8M
Goodwill$3.5M
Intangible Assets$575.0K
Tax Assets$70.0M
Other Non-current$9.1M
Total Non-current Assets$156.0M
Total Assets$684.2M

Analysis

Selected assets total $684.2M for Latest. The largest visible component is Inventory at $239.3M, about 35.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
SC 13GSC 13G filingAug 7, 2026

How much cash does ADMA have?

ADMA Biologics, Inc. (ADMA) reported $87.63M in cash and equivalents in fiscal 2025.

How much debt does ADMA carry?

ADMA Biologics, Inc. (ADMA) reported $79.89M of total debt, with net debt of -$7.75M.